Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Growth Shares
Got a spare $10,000 to invest? Smart investors should buy these ASX shares
Share Market News
5 things to watch on the ASX 200 next week
⏸️ Dividend Shares
Why it's always a good time to buy blue chip ASX shares
⏸️ ASX Shares
Why I would buy Cochlear (ASX:COH) and this ASX blue chip share
Growth Shares
3 excellent ASX growth shares to invest $3,000 immediately
⏸️ ASX Shares
Here's where you could invest your Woolworths (ASX:WOW) dividends today
⏸️ ASX Shares
3 ASX shares I want to buy in October
⏸️ ASX Shares
Top ASX Stock Picks for October 2020
Healthcare Shares
20% off: Here's why I think the Cochlear (ASX:COH) share price is a buy today
How to invest
How to be the next Warren Buffett with ASX shares
Share Fallers
Why Atlas Arteria, Cochlear, Telix, & Treasury Wine shares are dropping lower
Share Market News
The Aussie dollar at a critical juncture and could turn fortunes for these ASX stocks
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
